To access this page on Cerebrolysin® please confirm
that you are a healthcare professional.
NO, I AM NOT A HEALTHCARE PROFESSIONAL

Mediathek

GeneralMoAStrokeTBICognitive ImpairmentOutcomesCaregivers

General Information

Brochures

Mode of Action

Brochures

Videos

MoA - Introduction
MoA - Anti-Inflammatory Effect
MoA - Neuroplasticity
MoA - Neurogenesis
MoA - Reduction of post-stroke Dementia

Stroke

Brochures

Videos

CREGS - Launch
ESCAS - Aphasia
ESCAS Expert Interview
Treatments after stroke
Guideline Explainer Video
CARS Video
Expert Interview Stroke Guidelines
Expert Interview Winkler
Expert Interview Brainin

TBI

Brochures

Videos

From bench to bedside
CAPTAIN Video
Expert Interview Maas
Expert Interview Trimmel
Expert Interview Muresanu

Cognitive Impairment

Brochures

Videos

Mild Cognitive Impairment – Explainer Video

Outcomes

Brochures

Caregivers

Brochures

Rehabilitation Teaser Video
Rehabilitation after Stroke Video

Notice to U.S. Visitors

Please be advised that Cerebrolysin is not registered with the U.S. Food and Drug Administration (FDA) and is not approved for sale or distribution in the United States.

Cerebrolysin is a prescription medication for use under the supervision of an authorized health care professional. For any medical inquiries, please consult with a healthcare professional.